Clinical Trial Update: A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating abemaciclib in participants with varying degrees of liver impairment has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2019-01-22